A COMPARATIVE STUDY ON THE CLINICAL EFFECTS OF SILODOSIN AND NAFTOPIDIL IN JAPANESE PATIENTS WITH LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

Not Applicable

• Conditions: Benign Prostatic Hyperplasia

• Registration Number: JPRN-UMIN000008331
• Lead Sponsor: Kobe University Graduate School of Medicine, Division of Urology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2011-03-01
• Study Start: 2012-07-03
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Male
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients are having the disease other than a benign prostatic hyperplasia (prostate cancer, bladder tumors, bladder stones, prostatitis, bladder neck sclerosis, patients, etc.) 2) Patients have received TUR-P, balloon dilation, urethral stent, hyperthermia, or radiation therapy to the pelvis, within 6 months of the start of the study 3) Self-catheterization 4)Patients with urinary tract infection 5) Patients with concomitant disease and other nervous system diseases, and it suspected to be neurogenic bladder 6) Patients with concomitant severe ischemic heart disease, cerebrovascular disease, liver dysfunction, renal dysfunction. 7) Patients with hypotension 8) Patients are having hypersensitivity to silodosin, naftopidil or taking vardenafil hydrochloride 9) Patients have treated with hormonal drug within 6 months 10) Patients treated with drugs other than tamsulosin is considered effective on urinary symptoms within a week 11) Patients was deemed by the physician as inappropriate to attend

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
IPSS Score, QOL Score, Blood pressure

Secondary Outcome Measures

Name	Time	Method
maximum urinary flow rate (Qmax), residual urine volume